Position in ASND
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,430,150
-$21,839,786 QoQ
Shares Held
50,353
-67.3% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#82
of 307 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Derivatives in ASND
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$26,075,220
PutShares
114,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,023 across 417 Biotechnology names. ASND ranks #19 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in ASND
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,430,150 | 50,353 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $26,075,220 | 114,000 | Put | Defined | 2026-05-11 | |
| 2026-03-31 | $35,269,936 | 154,199 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $7,203,246 | 33,780 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $6,296,311 | 31,670 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $5,435,346 | 31,491 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,753,264 | 24,081 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,567,269 | 18,648 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,490,042 | 16,677 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,446,990 | 10,610 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,672,090 | 11,061 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,318,065 | 10,465 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $930,312 | 9,935 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $965,594 | 10,819 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,150,683 | 10,732 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,314,117 | 10,760 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $954,946 | 9,248 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $894,367 | 9,621 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $7,264,817 | 61,902 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,748,389 | 57,596 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $55,155,472 | 346,041 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,481,120 | 11,259 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,053,850 | 8,177 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $559,378 | 3,354 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $448,916 | 2,909 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $585,535 | 3,959 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $676,672 | 6,009 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||